Back
Agilent Technologies 10K Form
Buy
54
A
Agilent Technologies
Last Price:
131.94
Seasonality Move:
1.08%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2020-12-18 | 10K | A/Agilent Technologies Annual |
2020-09-01 | 10Q | A/Agilent Technologies Quarterly |
2020-06-01 | 10Q | A/Agilent Technologies Quarterly |
2020-03-03 | 10Q | A/Agilent Technologies Quarterly |
2019-12-19 | 10K | A/Agilent Technologies Annual |
2019-08-30 | 10Q | A/Agilent Technologies Quarterly |
Receive A News And Ratings
See the #1 stock for the next 7 days that we like better than A
A Financial Statistics
Sales & Book Value
Annual Sales: | $6.85B |
---|---|
Cash Flow: | $220M |
Price / Cash Flow: | 37.13 |
Annual Sales: | $18.95 |
Price / Book: | 6.96 |
Profitability
EPS (TTM): | 4.43000 |
---|---|
Net Income (TTM): | $1.32B |
Gross Margin: | $3.72B |
Return on Equity: | 25.17% |
Return on Assets: | 12.55% |
Agilent Technologies Earnings Forecast
Key Agilent Technologies Financial Ratios
- The Gross Profit Margin over the past 25 years for A is 54.35%.
- The Selling, General & Administrative Expenses for A have been equal to 23.90% of Gross Profit Margin.
- The Research & Development expenses have been 6.82% of Revenue.
- The Interest Expense is 6.70% of Operating Income.
- The Net Earning history of A is 18.31% of Total Revenues.
- Per Share Earnings over the last 25 years have been positive in 13 years.
Agilent Technologies Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Diagnostics & Research |
Sector: | Healthcare |
Current Symbol: | A |
CUSIP: | 00846U |
Website: | agilent.com |
Debt
Debt-to-Equity Ratio: | 0.53 |
---|---|
Current Ratio: | 2.11 |
Quick Ratio: | 1.4 |
Price-to-Earnings
Trailing P/E Ratio: | 31.57 |
---|---|
Forward P/E Ratio: | 20.89 |
A Technical Analysis vs Fundamental Analysis
Buy
54
Agilent Technologies (A)
is a Buy
Is Agilent Technologies a Buy or a Sell?
-
Agilent Technologies stock is rated a Buy
The current Agilent Technologies [A] share price is $131.96. The Score for A is 54, which is 8% above its historic median score of 50, and infers lower risk than normal.